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IASTAM aims at achieving a fuller understanding of Asian medicines in historical and contemporary contexts by integrating diverse forms of knowledge and ways of practice. It provides an epistemological framework for scholarly exchanges between medical anthropologists, practitioners of Asian medical traditions, specialists in life sciences, ethnobotanists, ethnopharmacologists, ethnopharmacognosists, herbalists, historians, economists, political scientists, conservationists, translators, and more. IASTAM includes the major scholarly medical traditions and various vernacular healing traditions of East Asia (China, Korea, Japan, Vietnam), South Asia (Ayurveda, Unani, Siddha, Yoga, Homeopathy, and others), Central Asia and the Himalayas (Tibet, Mongolia, etc.), along with Greco-Arabic traditions (as practiced in West and Central Asia, as well as North Africa). In light of this diversity, the ICTAMs provide opportunities to develop new networks of collaboration and exchange and to consider how both our association and the field as a whole can move forward.
IASTAM is unique in encompassing diverse national and international organizations related to Asian medical traditions. The association has the ability to speak on behalf of these different traditions and to provide a vibrant space for inter-and transdisciplinary exchange and for discussing points of intersection and tension between our various approaches and perspectives. We intend for the society and its future conferences, as well as its publications, to create a transnational forum within which practitioner bodies can work together in a supportive and collaborative way. This will allow IASTAM members to represent Asian medicines within the EU, North America, Australia, and elsewhere, to coordinate research, and to provide expert advice as required.
Traditional Asian medicines play a significant role in improving the wellbeing of people worldwide, both as health care systems in their own right and as resources for biodiscovery projects. As a multibillion-dollar industry, Asian medicines involve complex global networks of actors: conservators who monitor the changing supplies of wild plants in Asian mountains, medical botanists who study the substitution practices of collectors and marketers in Asia, policy-makers who restrict or prohibit the entry of drugs into European countries, corporations that seek to exploit drugs based on Asian medical knowledge, and professional associations that seek to regulate Asian medical practice. The types of agents and institutions involved in the production, distribution, and application of Asian medical therapies will only increase, and in this environment of industrialization, scientific validation will play a major role in the movement of such medicines across transnational regulatory frameworks.
